Hepatitis B surface antigen assays : operational characteristics (phase 1) : report 2
World Health Organization. Dept. of Essential Health Technologies. (2004). Hepatitis B surface antigen assays : operational characteristics (phase 1) : report 2. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/43031
In einem Verhältnis stehende Einträge
In einem Verhältnis stehende Einträge nach Titel, Verfasser, Urheber und Schlagwort anzeigen
Experimental conditions affecting the sensitivity of enzyme-linked immunosorbent assay (ELISA) for detection of hepatitis B surface antigen (HBsAg)* Fields, Howard A.; Davis, Candace L.; Bradley, Daniel W.; Maynard, James E. (1983)
Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria Egah, D.Z.; Banwat, E.B.; Audu, E.S.; Iya, D.; Mandong, B.M.; Anele, A.A.; Gomwalk, N.E. (2007)We investigated the seroprevalence of human immunodeficiency virus [HIV], hepatitis B virus [HBV] and hepatitis C virus [HCV] infection among 258 clergymen-in-training [age range 18-39 years] who represented a donor population that fulfilled the criteria for safe blood transfusion. In all, 15.1% of the men were positive for HBsAg, 4.3% were positive for anti-HCV and 2.7% were HIV- positive; 22.1% were infected with at least one of these viruses. Co-infection with HIV and HBV was found in 0.4% of the subjects, HBV and HCV in 0.4%, and HIV and HCV ...